Diazyme Laboratories, Inc.

Amarex is a global, full-service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services.

Sign-up to receive invites to webinars, training courses and the latest cutting-edge information on clinical trials: https://go.pardot.com/l/129231/2020-07-27/39ng9k

Founded in 1989 by the University of Colorado, CPC has two divisions. CPC Clinical Research is an academically led, non-profit, clinical research organization offering Phase 1 - 4 clinical research leadership and management services to sponsors around the world. CPC Clinical Research specializes in innovative research including a proprietary program, the Endpoint Quality Intervention Program (EQuIP), that helps reduce variability in the collection of endpoint data, allowing more definitive answers to the study objectives.

CPC Community Health creates innovative and educational programs to implement established cardiovascular prevention national guidelines and best evidence in Colorado communities resulting in improved cardiovascular health.

CPC is affiliated with the University Of Colorado School Of Medicine, Denver Health and the National Jewish Health. CPC is also the clinical trials arm of the University of Colorado Charles C Gates Center for Regenerative Medicine & Stem Cell Biology whose goal is to understand the biology of stem cells in order to develop new therapies for debilitating diseases such as heart diseases and vascular diseases.

CPC CLINICAL RESEARCH MISSION

To unite academic leadership with operational expertise to optimize the quality of clinical research and improve health.

CPC COMMUNITY HEALTH MISSION

Our mission is to improve the health of all Coloradans by creating innovative community health programs that deliver evidence-based interventions.

Visit us at www.cpcmed.org and www.communityhealth.org

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including the central nervous system, cardiovascular, metabolic, general medicine, oncology, and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit http://www.worldwide.com.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated."

AltheaDx is a commercial stage molecular diagnostics company specializing in the field of pharmacogenetics, or PGx. IDgenetix, our PGx product testing portfolio, enables personalized therapeutic decisions for patients suffering from some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders, and pain.